American Journal on Addictions

Papers
(The median citation count of American Journal on Addictions is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Issue Information40
Stand against stigma29
AAAP's Annual Meeting and Scientific Symposium29
AAAP 36th Annual Meeting & Scientific Symposium Save the Date27
Call for Special Issue 202425
AAAP Stimulant Use Disorder PIP24
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada24
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression21
2024 Annual Meeting Posters20
Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada19
Gender differences in circumstances associated with cannabis use19
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment16
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey15
A scoping review of sensory‐based interventions to address alcohol consumption15
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances14
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–202113
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort12
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States12
AAAP Annual meeting ad12
Longitudinal pathway from low academic performance in adolescence to prescription drug misuse in adulthood: The mediating role of substance use and the moderating role of sex12
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia11
Call for Special Issue Papers 202511
AM Registration Flyer11
Synthetic cannabinoid use and the acquired preparedness model11
Call for Review Papers 202411
Become a member of AAAP!11
Tobacco use and impulsivity in people with mental illness: A systematic review10
PCSS‐MOUD AND ORN: Find out more about AAAP's national grant initiatives10
AAAP MEMBERSHIP: Reap the benefits of belonging to AAAP10
2025 AAAP Case Conference10
Narcotics Anonymous members in recovery from methamphetamine use disorder9
Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms9
Emotional regulation in Gaming Disorder: A systematic review8
Correlates of optimism among patients in substance use disorder inpatient treatment8
Call for Review Papers 20248
Cannabis cessation and neurocognitive recovery: Patterns, predictors, and clinical implications—a systematic review8
Call for Special Issue Papers 20248
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study7
Issue Information ‐ ToC7
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?7
AJA Annual Meeting 20237
Call for review papers 20227
Preconference On‐Demand availability7
Issue Information7
Issue Information ‐ Editorial Board7
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study7
AAAP AATT Preconference6
AAAP Call for Abstracts6
Call for Review Papers 20256
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates6
Extended‐release buprenorphine in pregnancy6
AAAP Podcast EP6
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications6
Issue Information ‐ Editorial Board5
2023 Advanced Addiction Psychopharmacology Course5
AAAP MEMBERSHIP: Reap the benefits of belonging to AAAP5
SAVE THE DATE: Don't miss out on next year's Annual Meeting, held in Memphis, TN!5
Stand Against Stigma5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us5
Wanted: SPC Members: Join AAAP's Scientific Program Committee (SPC) and shape the future of the Academy5
Issue Information ‐ ToC5
BREAKING NEWS: AAAP Earns a Spot in ACCME's Innovation Partner Circle!5
Personality predicting relapse: A facet analysis of the NEO PI‐R5
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population5
Issue Information5
AAAP's Performance in practice activities4
Health care service utilization and drug overdose death: A national nested case–control registry study4
Psychedelic‐assisted therapy for substance use disorders: Between urgency and uncertainty4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs4
Addiction specialists' attitudes toward psychedelics: A National Survey4
Shining a light on alcohol use disorder through the eyes of the patient: Improving recognition and management4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study4
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder4
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)4
Call for Special Issue Papers 20254
Call for special issue 20234
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting3
AAAP Membership benefits3
3
SAVE THE DATE: Don't miss out on next year's Annual Meeting, held in Memphis, TN!3
AJA AM save the date 20233
2021 AJA Reviewer List3
Cannabis Use Disorders Performance in Practice3
Association between experiencing gambling problems and adverse behavioral health outcomes among U.S. military service members, 20183
Issue Information ‐ Editorial Board3
3
Call for Review Papers 20263
Call for Special Issue 20233
Treating beyond the city limits: Building capacity in all communities3
AJA AM Save the Date 20233
AAAP NEWSLETTER: What do your colleagues have to say about the latest updates in Addiction Psychiatry?3
Stand Against Stigma3
2023 Addictions and Their Treatment Course3
Call for Symposium Abstracts3
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders2
Issue Information ‐ Editorial Board2
2025 Call for Symposium Abstracts2
FREE WEBINAR: Master MI Techniques with Dr. Brian Borsari, September 10, 20252
AAAP 2024 Self‐Assessment Exam Now Available2
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem2
Gambling, tobacco use, and health among individuals in substance use disorder treatment2
Call for Review Papers 20262
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth2
Call for Review Papers 20232
Trends in substance use disorder diagnoses among Veterans, 2009–20192
Psychotherapy Webinar Series AJA2
Mini‐Symposia I2
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort2
2
36th AAAP Annual Meeting and Scientific Symposium Recap2
Concurrent Paper Sessions2
Paper sessions2
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series2
Become an AAAP Member2
Save the Date ‐ Annual Meeting 20252
Medical Update2
Medication Management for Stimulant Use Disorder Webinar2
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis1
AJA Psychedelics1
Symposium III1
Session name: Medical update1
Call for special issue 20231
2025 Combined Poster File1
AAAP Membership1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics1
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic1
Addiction Psychiatry Advanced Psychotherapy Curriculum1
Opioid Recover Network ‐ ORN: Recruiting qualified consultants for the ORN1
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem1
Film & Media Workshop1
Call for Special Issue Papers 20261
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization1
Call for special issue 20231
The mediating role of impulsivity in the relationship between childhood maltreatment and depression in methamphetamine patients1
Examining family member characteristics by treatment status of the relative with substance use problems1
Mini‐Symposia II1
Call for Special Issue Papers 20261
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 20241
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study1
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients1
NEW SELF ASSESSMENT EXAM: Get ready for the boards with this re‐vamped self‐assessment exam1
Call for special issue 20231
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study1
Daily cannabis use may cause cannabis‐induced hyperalgesia1
Cannabis and the overdose crisis among US adolescents1
Nicotine use and patient‐directed discharge rate in psychiatric inpatients: A retrospective cohort1
PCSS exchange AJA Ad1
Conference Schedule1
Issue Information1
NEW BUNDLED COURSES: Save big on these bundled courses as you prepare for the boards1
Symposium I1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?1
2024 Annual Meeting Posters1
Opioid use disorder in the active service: Implications for intervention1
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review1
Cannabis Use PIP Ad1
Addiction Psychiatry Advanced Psychotherapy Curriculum1
Call for review papers 20221
2023 Advanced Addiction Psychopharmacology Course1
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use0
NEW SELF ASSESSMENT EXAM: Get ready for the boards with this re‐vamped self‐assessment exam0
Become a AAAP Member0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey0
Issue Information0
Response to commentary, from Bisol et al., on “Tobacco use and impulsivity in people with mental illness: A systematic review,Praecht, A. et al. (2025). Am. J. Addict. 34–4: 383–4030
Motivational Interviewing PIP0
Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study0
Trends in racial/ethnic and geographic disparities in substance use disorders mortality in the United States, 2000–20190
Symposium IV0
AAAP Podcast Addiction & Zyn Tackling Tobacco and Nicotine Use Disorder in 20250
Estimating the effects of prenatal cannabis exposure on birth outcomes0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study0
FREE Online Self‐Assessment Exam: ORN StUD Performance in Practice (PIP)0
Psychotherapy Webinar Series AJA0
Managing Opioid Use Disorder Care in the Era of Fentanyl0
Become A AAAP Member!0
Identifying treatment responders to the combination of varenicline and naltrexone0
Response to Costa et al.: Caution is warranted when comparing estimates from differently defined study samples0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial0
2024 Reviewer List0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US0
AAAP's Educational Offerings0
Motivational Interviewing Performance in Practice0
Issue Information0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance0
AAAP PIPS 20230
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 20240
FREE WEBINAR: Cultural Considerations in Tribal Behavioral Health Practice, December 10, 20250
Travel Award AJA0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone0
AAAP Performance and Practice (PIP) Resources0
AAAP Travel Awards Open0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder0
Issue Information ‐ Editorial Board0
Addictions and their treatment0
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients0
Symposium IV0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths0
Symposia, Medical Update, and Case Conference0
0
AAAP podcast0
FREE Training & Mentoring: PCSS and ORN0
Addictions & Their Treatment Virtual Course, Sep 13‐14, 2024 ‐ 50% Discount Preconference 50% Off 2023 Self Assessment Exam0
Call for Review Papers 20240
High‐intensity transcranial alternating current stimulation for gambling disorder comorbidities with alcohol use disorders: A case report0
Medication treatment for alcohol use disorder in special populations0
Call for Special Issue 20220
Gender differences in the prevalence of stimulant misuse in the United States: 2015–20190
Issue Information0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood0
Double trouble ‐ Examining the co‐occurrence of compulsive sexual behavior disorder and gambling disorder among two American samples0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder0
CSAM‐SMCA 2022 Scientific conference and annual meeting0
Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate0
Film & Media Workshop0
Become a AAAP Member0
Imposter syndrome and college students' drinking behaviors: The roles of negative affect and coping motivated alcohol use0
AAAP_Call for Review papers‐20240
2023 Reviewer List (n = 223)0
Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate0
AAAP Podcast0
Tobacco/nicotine use among individuals using cannabis for therapeutic purposes0
0
Call for review papers 20220
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?0
Registration Open Now: Virtual Courses on Addictions and Their Treatment (Sep 12–13, 2025) and Advanced Addiction Psychopharmacology (Sep 20–21, 2025)0
Medical marijuana access and prolonged opioid use among adolescents and young adults0
Call for Review Papers 20250
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience0
Issue Information0
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping review0
Issue Information0
NEW BUNDLED COURSES: Save big on these bundled courses as you prepare for the boards0
AJA psychedelic Ad0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O0
Reasons for electronic cigarette use: Differences based on sex and young adult status0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study0
Differential mortality among US veterans: Social determinants of health, substance use disorder, and substance use treatment0
Conference Schedule0
AAAP Psychotherapy Curriculum Series0
Issue Information0
0.12383604049683